Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D001463:Barbiturates / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000517:prevention & control; D001780:Blood Coagulation Tests; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced* / Q000517:prevention & control; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014812:Vitamin K / Q000627:therapeutic use
D000927:Anticonvulsants; D001463:Barbiturates; D014812:Vitamin K; D010672:Phenytoin